Non-Invasive Diagnosis of Gastroesophageal Reflux Disease Using Gastrin- and Pepsinogen-Based Tests
By:
References
- Abe, Y., Iijima, K., Koike, T., Asanuma, K., Imatani, A., Ohara, S., Shimosegawa, T. (2009). Barrett’s esophagus is characterized by the absence of Helicobacter pylori infection and high levels of serum pepsinogen I concentration in Japan. J. Gastroenterol. Hepatol., 24 (1), 129–134.
- Collen, M. J., Johnson, D. A. (1992). Correlation between basal acid output and daily ranitidine dose required for therapy in Barrett’s esophagus. Digestive Dis. Sci., 37 (4), 570–576.
- Dixon, M. F., Genta, R. M., Yardley, J. H., Correa, P. (1996). Classification and grading of gastritis. The updated Sydney System. International workshop on the histopathology of gastritis, Houston 1994. Amer. J. Surg. Pathol., 20 (10), 1161–1181.
- Dockray, G. J. (2004). Clinical endocrinology and metabolism. Gastrin. Best Practice Res. Clin. Endocrin. Metab., 18 (4), 555–568.
- Fujiwara, Y., Higuchi, K., Shiba, M., Yamamori, K., Watanabe, Y., Sasaki, E., Tominaga, K., Watanabe, T., Oshitani, N., Arakawa, T. (2005). Differences in clinical characteristics between patients with endoscopy-negative reflux disease and erosive esophagitis in Japan. Amer. J. Gastroenterol., 100 (4), 754–758.
- Gritti, I., Banfi, G., Roi, G. S. (2000). Pepsinogens: Physiology, pharmacology pathophysiology and exercise. Pharmacol. Res., 41 (3), 265–281.
- Iijima, K., Abe, Y., Kikuchi, R., Koike, T., Ohara, S., Sipponen, P. (2009). Serum biomarker tests are useful in delineating between patients with gastric atrophy and normal, healthy stomach. World J. Gastroenterol., 15 (7), 853–859.
- Katz, P., Gerson, L. B., Vela, M. F. (2013). Guidelines for the diagnosis and management of gastroesophageal reflux disease. Amer. J. Gastroenterol., 108 (3), 308–328.
- Kuipers, E. J. (2003). In through the out door: Serology for atrophic gastritis. Eur. J. Gastroenterol. Hepatol., 15 (8), 877–879.
- Lundell, L. R., Dent, J., Bennett, J. R., Blum, A. L., Armstrong, D., Galmiche, J. P., Johnson, F., Hongo, M., Richter, J. E., Spechler, S. J., Tytgat, G. N., Wallin, L. (1999). Endoscopic assessment of eosophagitis: clinical and functional correlates and futher validation of the Los Angeles classification. Gut, 45 (2), 172–180.
- Minatsuki, C., Yamamichi, N., Shimamoto, T., Kakimoto, H., Takahashi, Y., Fujishiro, M., Sakaguchi, Y., Nakayama, C., Konno-Shimizu, M., Matsuda, R., Mochizuki, S., Asada-Hirayama, I., Tsuji, Y., Kodashima, S., Ono, S., Niimi, K., Mitsushima, T., Koike, K. (2013). Background factors of reflux esophagitis and non-erosive reflux disease: A cross-sectional study of 10,837 subjects on Japan. PLOS ONE, 8 (7). DOI: 10.1371/journal.pone.0069891.
- Monkemuller, K., Neumann, H., Nocon, M., Vieth, M., Labenz, J., Willich, S. N., Stolte, M., Hocker, M., Jaspersen, D., Lind, T., Malftheiner, P. (2008). Serum gastrin and pepsiongens do not correlate with the different grades of severity of gastro-oesophageal reflux disease: A matched case-control study. Alimentary Pharmacol. Ther., 28 (4), 491–496.
- Mulholland, N. M., Reid, B. J., Levine, D. S., Rubin, C. E. (1989). Elevated gastric acid secretion in patients with Barrett’s metaplastic epithelium. Digest. Dis. Sci., 34 (9), 1329–1334.
- Narsollahzadeh, D., Aghcheli, K., Sotoudeh, M., Shakeri, R., Persson, E. C., Islami, F., Kamangar, F., Abnet, C. C., Boffetta, P., Engstrand, L., Dawsey, S. M., Malekzadeh, R., Ye, W. (2011). Accuracy and cut-off values of pepsinogens I, II and gastrin 17 for diagnosis of gastric fundic atrophy: Influence of gastritis. PLOS ONE, 6 (10). DOI: 10.1371/journal.pone.0026957.10.1371/journal.pone.0026957
- Pasechnikov, V. D., Chukov, S. Z., Kotelevets, S. M., Mostovov, A. N., Mernova, V. P., Polyakova, M. B. (2005). Invasive and non-invasive diagnosis of Helicobacter pylori-associated atrophic gastritis: A comparative study. Scand. J. Gastroenterol., 40 (3), 297–301.
- Peitz, U., Wex, T., Vieth, M., Stolte, M., Willich, S., Labenz, J., Jaspersen, D., Lind, T., Malfertheiner, P. (2011). Correlation of serum pepsinogens and gastrin-17 with atrophic gastritis in gastroesophageal reflux patients: A matched-pairs study. J. Gastroenterol. Hepatol., 26 (1), 82–89.
- Sipponen, P., Vauhkonen, M., Helske, T., Kaariainen, I., Harkonen, M. (2005). Low circulating levels of gastrin-17 in patients with Barrett’s esophagus. World J. Gastroenterol., 11 (38), 5988–5992.
- Tack, J., Talley, N. J., Camilleri, M., Holtmann, G., Hu, P., Malagelada, J.-R., Stanghellini, V. (2006). Functional gastroduodenal disorders. Gastroenterology, 130 (5), 1466–1479.
- Vaananen, H., Vauhkonen, M., Helske, T., Kaariainen, I., Rasmussen, M., Tunturi-Hihnala, H., Koskenpato, J., Sotka, M., Turunen, M., Sandstrom, R., Ristikankare, M., Jussila, A., Sipponen, P. (2003). Non-endoscopic diagnosis of atrophic gastritis with a blood test. Correlation between gastric histology and serum levels of gastrin-17 and pepsinogen I: A multicentre study. Eur. J. Gastroenterol. Hepatol., 15 (8), 885–891.
- Yoshikawa, I., Murata, I., Kume, K., Kanagawa, K., Hirohata, Y., Nakamura, H., Otsuki, M. (2002). Serum pepsinogen can predict response to H2-receptor antagonist in patients with functional dyspepsia. Alimentary Pharmacol. Ther., 16 (10), 1805–1809.
Language: English
Page range: 172 - 176
Submitted on: Sep 17, 2017
Accepted on: Jan 7, 2018
Published on: Jun 21, 2018
Published by: Latvian Academy of Sciences
In partnership with: Paradigm Publishing Services
Publication frequency: 6 issues per year
Related subjects:
© 2018 Georgijs Moisejevs, Ilva Daugule, Sergejs Isajevs, Dace Rudzīte, Dainius Janciauskas, Ivars Tolmanis, Marcis Leja, published by Latvian Academy of Sciences
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.